⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9311207 | 0.94 | AGTR1 (0.47) | — | |
| SCHEMBL9678102 | 0.94 | — | — | |
| SCHEMBL9309099 | 0.94 | AGTR1 (0.50) | — | |
| SCHEMBL9677384 | 0.93 | — | — | |
| SCHEMBL9312065 | 0.91 | — | — | |
| SCHEMBL9309765 | 0.91 | — | — | |
| SCHEMBL9678258 | 0.91 | — | — | |
| SCHEMBL9309252 | 0.88 | AGTR1 (0.54) | — | |
| SCHEMBL9678069 | 0.88 | — | — | |
| SCHEMBL9308979 | 0.87 | AGTR1 (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5374646-A | Treatment or prophylasix of hypertension and diseases associated with cognitive disorders | GLAXO GROUP LIMITED (GB) | 1994-12-20 | — | — | US | disclosed |